Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/53961
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2020-04-09T08:21:24Z-
dc.date.available2020-04-09T08:21:24Z-
dc.date.issued2016-
dc.identifier.citationGrech. L., Ferrito, V., Camilleri, L., Serracino-Inglott, A., & Azzopardi, L. M. (2016). Pharmaceutical care models, tools for treating patients with rheumatoid arthritis. The Rheumatologist. Retrieved from https://www.the-rheumatologist.org/article/pharmaceutical-care-models-tools-for-treating-patients-with-rheumatoid-arthritis/en_GB
dc.identifier.urihttps://www.um.edu.mt/library/oar/handle/123456789/53961-
dc.description.abstractRheumatoid arthritis (RA) can be defined as a chronic autoimmune systemic inflammatory condition characterized by symmetrical polyarthritis. Typically, patients present with pain, stiffness and warmth of the affected joints. The condition can result in extra-articular features, adding to disability, and may eventually lead to premature death, especially if not treated early and appropriately.1,2 Over the past 20 years, the drugs available for treating RA have increased drastically, leading to revised pharmacotherapy strategies. As Bijlsma points out in an article published in 2010, the main changes in RA management were due to new drugs, namely biologics. In turn, these drugs led to improved treatment strategies and a joint European League Against Rheumatism (EULAR)–American College of Rheumatology (ACR) work group, which devised the “treat to target” concept.3-5 The biologic era led to the availability of biosimilars, which are affecting the pharmacoeconomic aspect of the financial expenses of many national health services.en_GB
dc.language.isoenen_GB
dc.publisherACRen_GB
dc.rightsinfo:eu-repo/semantics/openAccessen_GB
dc.subjectRheumatoid arthritisen_GB
dc.subjectArthritis -- Popular worksen_GB
dc.subjectArthritis -- Preventionen_GB
dc.subjectRheumatoid arthritis -- Diagnosisen_GB
dc.titlePharmaceutical care models, tools for treating patients with rheumatoid arthritisen_GB
dc.typearticleen_GB
dc.rights.holderThe copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder.en_GB
dc.description.reviewedN/Aen_GB
dc.publication.titleThe Rheumatologisten_GB
dc.contributor.creatorGrech, Louise-
dc.contributor.creatorFerrito, Victor-
dc.contributor.creatorCamilleri, Liberato-
dc.contributor.creatorSerracino-Inglott, Anthony-
dc.contributor.creatorAzzopardi, Lilian M.-
Appears in Collections:Scholarly Works - FacM&SPha

Files in This Item:
File Description SizeFormat 
Pharmaceutical Care Models Tools for Treating Patients with Rheumatoid Arthritis.pdf259.31 kBAdobe PDFView/Open


Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.